Davies Simon J C, Hood Sean D, Argyropoulos Spilios V, Morris Kelly, Bell Caroline, Witchel Harry J, Jackson Peter R, Nutt David J, Potokar John P
Psychopharmacology Unit, University of Bristol, Whitson Street, Bristol BS1 8NY, United Kingdom.
J Clin Psychopharmacol. 2006 Aug;26(4):414-8. doi: 10.1097/01.jcp.0000227704.79740.c0.
Serotonin-promoting drugs show cardioprotective properties in patients with anxiety or depression, but it is not known if this is a direct effect of increasing serotonin. We aimed to characterize the effect of serotonin manipulation through acute tryptophan depletion on cardiovascular and psychological responses to stress challenge in recovered patients with anxiety disorders. In 27 recovered patients with anxiety disorders (panic disorder treated by selective serotonin reuptake inhibitors (SSRIs) or cognitive behavioral therapy, social anxiety disorder treated by SSRIs), we performed a double-blind randomized crossover study. On 2 separate days, the subjects ingested an acute tryptophan-depleting (aTD) or nondepleting (nD) drink in random order and underwent a stress challenge at time of maximum depletion. Systolic blood pressure (P = 0.007; diff = 9.0 mm Hg; 95% confidence interval (CI), 2.6-15.3 mm Hg) and diastolic blood pressure (P = 0.032; diff = 5.7 mm Hg; 95% CI, 0.6-10.9 mm Hg) responses to stress were significantly greater under aTD than nD, as were the psychological responses to stress (for Spielberger state anxiety, difference in stress response between aTD and nD = 7.11; P = 0.025). Blood pressure responses to stress showed no correlation with psychological responses. The significant increases in acute stress sensitivity in both cardiovascular and psychological domains on serotonin depletion suggest that serotonin is involved in the control of both cardiovascular and psychological aspects of the acute stress response. The lack of correlation in the difference between aTD and nD conditions in cardiovascular and psychological responses suggests that serotonin may have distinct effects on these 2 domains, rather than the cardiovascular responses being merely a secondary consequence of psychological changes.
促进血清素的药物在焦虑或抑郁患者中显示出心脏保护特性,但尚不清楚这是否是血清素增加的直接作用。我们旨在通过急性色氨酸耗竭来表征血清素操纵对焦虑症康复患者心血管和心理应激反应的影响。在27名焦虑症康复患者(通过选择性血清素再摄取抑制剂(SSRI)或认知行为疗法治疗的恐慌症,通过SSRI治疗的社交焦虑症)中,我们进行了一项双盲随机交叉研究。在2个不同的日子里,受试者随机顺序摄入急性色氨酸耗竭(aTD)或非耗竭(nD)饮料,并在最大耗竭时接受应激挑战。与nD相比,aTD下对应激的收缩压(P = 0.007;差异= 9.0毫米汞柱;95%置信区间(CI),2.6 - 15.3毫米汞柱)和舒张压(P = 0.032;差异= 5.7毫米汞柱;95%CI,0.6 - 10.9毫米汞柱)反应显著更大,对应激的心理反应也是如此(对于斯皮尔伯格状态焦虑,aTD和nD之间的应激反应差异= 7.11;P = 0.025)。血压对应激的反应与心理反应无相关性。血清素耗竭时心血管和心理领域急性应激敏感性的显著增加表明,血清素参与了急性应激反应的心血管和心理方面的控制。aTD和nD条件下心血管和心理反应差异缺乏相关性表明,血清素可能对这两个领域有不同的影响,而不是心血管反应仅仅是心理变化的次要后果。